Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
Cell Chem Biol ; 30(12): 1501-1504, 2023 12 21.
Article in English | MEDLINE | ID: mdl-38134879

ABSTRACT

Current methods have limited ability in directly quantifying the extent of glutathionylation on specific protein-cysteines. In this issue of Cell Chemical Biology, Ahn et al.1 report G-ICAT (glutathione-based isotope-coded affinity tag), aimed at addressing this limitation. G-ICAT identifies Cysteine-692 within p120-catenin-a member of cadherin complex essential for cell-cell-contact maintenance-where C692-specific glutathionylation promotes E-cadherin destabilization.


Subject(s)
Cadherins , Cysteine
2.
J Med Chem ; 64(21): 15991-16007, 2021 11 11.
Article in English | MEDLINE | ID: mdl-34706190

ABSTRACT

Disruption of redox homeostasis in mycobacteria causes irreversible stress induction and cell death. Here, we report the dioxonaphthoimidazolium scaffold as a novel redox cycling antituberculosis chemotype with potent bactericidal activity against growing and nutrient-starved phenotypically drug-resistant nongrowing bacteria. Maximal potency was dependent on the activation of the redox cycling quinone by the positively charged scaffold and accessibility to the mycobacterial cell membrane as directed by the lipophilicity and conformational characteristics of the N-substituted side chains. Evidence from microbiological, biochemical, and genetic investigations implicates a redox-driven mode of action that is reliant on the reduction of the quinone by type II NADH dehydrogenase (NDH2) for the generation of bactericidal levels of the reactive oxygen species (ROS). The bactericidal profile of a potent water-soluble analogue 32 revealed good activity against nutrient-starved organisms in the Loebel model of dormancy, low spontaneous resistance mutation frequency, and synergy with isoniazid in the checkerboard assay.


Subject(s)
Antitubercular Agents/pharmacology , Imidazoles/pharmacology , Mycobacterium tuberculosis/drug effects , Animals , Antitubercular Agents/chemistry , Antitubercular Agents/pharmacokinetics , Bacterial Proteins/metabolism , Cell Wall/drug effects , Genes, Reporter , Imidazoles/chemistry , Imidazoles/pharmacokinetics , Microbial Sensitivity Tests , Mycobacterium tuberculosis/metabolism , NADH Dehydrogenase/metabolism , Oxidation-Reduction , Rats , Reactive Oxygen Species/metabolism , Structure-Activity Relationship , Up-Regulation
3.
Diabetes ; 68(4): 819-831, 2019 04.
Article in English | MEDLINE | ID: mdl-30728184

ABSTRACT

Proximal tubular epithelial cells are highly energy demanding. Their energy need is covered mostly from mitochondrial fatty acid oxidation. Whether derailments in fatty acid metabolism and mitochondrial dysfunction are forerunners of tubular damage has been suggested but is not entirely clear. Here we modeled mitochondrial overload by creating mice lacking the enzyme carnitine acetyltransferase (CrAT) in the proximal tubules, thus limiting a primary mechanism to export carbons under conditions of substrate excess. Mice developed tubular disease and, interestingly, secondary glomerulosclerosis. This was accompanied by increased levels of apoptosis regulator and fibrosis markers, increased oxidative stress, and abnormal profiles of acylcarnitines and organic acids suggesting profound impairments in all major forms of nutrient metabolism. When mice with CrAT deletion were fed a high-fat diet, kidney disease was more severe and developed faster. Primary proximal tubular cells isolated from the knockout mice displayed energy deficit and impaired respiration before the onset of pathology, suggesting mitochondrial respiratory abnormalities as a potential underlying mechanism. Our findings support the hypothesis that derailments of mitochondrial energy metabolism may be causative to chronic kidney disease. Our results also suggest that tubular injury may be a primary event followed by secondary glomerulosclerosis, raising the possibility that focusing on normalizing tubular cell mitochondrial function and energy balance could be an important preventative strategy.


Subject(s)
Carnitine O-Acetyltransferase/metabolism , Kidney Diseases/metabolism , Kidney Tubules, Proximal/metabolism , Kidney/metabolism , Animals , Apoptosis/physiology , Carnitine O-Acetyltransferase/genetics , Diet, High-Fat , Electron Transport Complex I/metabolism , Kidney/pathology , Kidney Diseases/genetics , Kidney Diseases/pathology , Kidney Tubules, Proximal/pathology , Lipid Metabolism , Male , Mice , Mitochondria/metabolism , Oxidative Stress/physiology
4.
Clin Cardiol ; 41(10): 1300-1307, 2018 Oct.
Article in English | MEDLINE | ID: mdl-30350416

ABSTRACT

BACKGROUND: Aerobic capacity is a powerful predictor of cardiovascular disease and all-cause mortality, and it declines with advancing age. HYPOTHESIS: Since physical activity alters body metabolism, metabolism markers will likely differ between subjects with high vs low aerobic capacities. METHODS: Community-based participants without physician-diagnosed heart disease, stroke or cancer underwent same-day multimodal assessment of cardiovascular function (by echocardiography and magnetic resonance feature tracking of left atrium) and aerobic capacity by peak oxygen uptake (VO2 ) metrics. Associations between VO2 and cardiovascular and metabolomics profiles were studied in adjusted models including standard covariates. RESULTS: We studied 141 participants, of whom 82 (58.2%) had low VO2 , while 59 (41.8%) had high VO2 . Compared to participants with high VO2 , participants with low VO2 had more adverse cardiovascular parameters, such as lower ratio of peak velocity flow in early diastole to peak velocity flow in late diastole by atrial contraction of >0.8 (76% vs 35%, adjusted odd ratio [OR] = 4.1, 95% confidence interval [CI] [1.7-9.5], P = 0.001) and lower left atrial conduit strain (11.3 ± 4.0 vs 15.6 ± 6.1%, adjusted OR = 1.1, 95% CI [1.002-1.3], P = 0.045). High VO2 was associated with lower accumulation of wide-spectrum acyl-carnitines (OR = 0.6, 95% CI [0.4-0.9], P = 0.013), alanine (OR = 0.1, 95% CI [0.01-0.9], P = 0.044) and glutamine /glutamate (OR = 0.1, 95% CI [0.01-0.5], P = 0.007), compared to low VO2. CONCLUSION: Elderly adults with low VO2 have adverse cardiovascular and metabolic parameters compared to their counterparts with high VO2 . Combined cardiac and metabolomics phenotyping may be a promising tool to provide insights into physiological states, useful for tracking future interventions related to physical activity among community cohorts.


Subject(s)
Cardiovascular Diseases/metabolism , Exercise Tolerance/physiology , Exercise/physiology , Metabolomics/methods , Oxygen Consumption/physiology , Oxygen/metabolism , Age Distribution , Age Factors , Aged , Cardiovascular Diseases/mortality , Cardiovascular Diseases/physiopathology , Cause of Death/trends , Exercise Test , Female , Follow-Up Studies , Humans , Magnetic Resonance Imaging, Cine , Male , Prognosis , Prospective Studies , Singapore/epidemiology , Survival Rate/trends
5.
J Biol Chem ; 291(46): 23978-23988, 2016 Nov 11.
Article in English | MEDLINE | ID: mdl-27703011

ABSTRACT

The accumulation of sphingolipids in obesity leads to impairments in insulin sensitivity and mitochondrial metabolism, but the precise species driving these defects is unclear. We have modeled these obesity-induced effects in cultured C2C12 myotubes, using BSA-conjugated palmitate to increase synthesis of endogenous sphingolipids and to inhibit insulin signaling and oxidative phosphorylation. Palmitate (a) induced the accumulation of sphingomyelin (SM) precursors such as sphinganine, dihydroceramide, and ceramide; (b) inhibited insulin stimulation of a central modulator of anabolic metabolism, Akt/PKB; (c) inhibited insulin-stimulated glycogen synthesis; and (d) decreased oxygen consumption and ATP synthesis. Under these conditions, palmitate failed to alter levels of SMs, which are the most abundant sphingolipids, suggesting that they are not the primary intermediates accounting for the deleterious palmitate effects. Treating cells with a pharmacological inhibitor of SM synthase or using CRISPR to knock out the Sms2 gene recapitulated the palmitate effects by inducing the accumulation of SM precursors and impairing insulin signaling and mitochondrial metabolism. To profile the sphingolipids that accumulate in obesity, we performed lipidomics on quadriceps muscles from obese mice with impaired glucose tolerance. Like the cultured myotubes, these tissues accumulated ceramides but not SMs. Collectively, these data suggest that SM precursors such as ceramides, rather than SMs, are likely nutritional antagonists of metabolic function in skeletal muscle.


Subject(s)
Ceramides/metabolism , Insulin/metabolism , Mitochondria, Muscle/metabolism , Muscle Fibers, Skeletal/metabolism , Obesity/metabolism , Signal Transduction , Sphingomyelins/metabolism , Animals , Cell Line , Ceramides/genetics , Gene Deletion , Insulin/genetics , Mice , Mitochondria, Muscle/genetics , Obesity/genetics , Oxygen Consumption/genetics , Proto-Oncogene Proteins c-akt/genetics , Proto-Oncogene Proteins c-akt/metabolism , Sphingomyelins/genetics , Transferases (Other Substituted Phosphate Groups)/genetics , Transferases (Other Substituted Phosphate Groups)/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL